Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Articles, Neurobiology of Disease

β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin

Qiu-Lan Ma, Fusheng Yang, Emily R. Rosario, Oliver J. Ubeda, Walter Beech, Dana J. Gant, Ping Ping Chen, Beverly Hudspeth, Cory Chen, Yongle Zhao, Harry V. Vinters, Sally A. Frautschy and Greg M. Cole
Journal of Neuroscience 15 July 2009, 29 (28) 9078-9089; DOI: https://doi.org/10.1523/JNEUROSCI.1071-09.2009
Qiu-Lan Ma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fusheng Yang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily R. Rosario
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver J. Ubeda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter Beech
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dana J. Gant
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ping Ping Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beverly Hudspeth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cory Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yongle Zhao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harry V. Vinters
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sally A. Frautschy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Greg M. Cole
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Both insulin resistance (type II diabetes) and β-amyloid (Aβ) oligomers are implicated in Alzheimer's disease (AD). Here, we investigate the role of Aβ oligomer-induced c-Jun N-terminal kinase (JNK) activation leading to phosphorylation and degradation of the adaptor protein insulin receptor substrate-1 (IRS-1). IRS-1 couples insulin and other trophic factor receptors to downstream kinases and neuroprotective signaling. Increased phospho-IRS-1 is found in AD brain and insulin-resistant tissues from diabetics. Here, we report Aβ oligomers significantly increased active JNK and phosphorylation of IRS-1 (Ser616) and tau (Ser422) in cultured hippocampal neurons, whereas JNK inhibition blocked these responses. The omega-3 fatty acid docosahexaenoic acid (DHA) similarly inhibited JNK and the phosphorylation of IRS-1 and tau in cultured hippocampal neurons. Feeding 3xTg-AD transgenic mice a diet high in saturated and omega-6 fat increased active JNK and phosphorylated IRS-1 and tau. Treatment of the 3xTg-AD mice on high-fat diet with fish oil or curcumin or a combination of both for 4 months reduced phosphorylated JNK, IRS-1, and tau and prevented the degradation of total IRS-1. This was accompanied by improvement in Y-maze performance. Mice fed with fish oil and curcumin for 1 month had more significant effects on Y-maze, and the combination showed more significant inhibition of JNK, IRS-1, and tau phosphorylation. These data indicate JNK mediates Aβ oligomer inactivation of IRS-1 and phospho-tau pathology and that dietary treatment with fish oil/DHA, curcumin, or a combination of both has the potential to improve insulin/trophic signaling and cognitive deficits in AD.

View Full Text
Back to top

In this issue

The Journal of Neuroscience: 29 (28)
Journal of Neuroscience
Vol. 29, Issue 28
15 Jul 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin
Qiu-Lan Ma, Fusheng Yang, Emily R. Rosario, Oliver J. Ubeda, Walter Beech, Dana J. Gant, Ping Ping Chen, Beverly Hudspeth, Cory Chen, Yongle Zhao, Harry V. Vinters, Sally A. Frautschy, Greg M. Cole
Journal of Neuroscience 15 July 2009, 29 (28) 9078-9089; DOI: 10.1523/JNEUROSCI.1071-09.2009

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin
Qiu-Lan Ma, Fusheng Yang, Emily R. Rosario, Oliver J. Ubeda, Walter Beech, Dana J. Gant, Ping Ping Chen, Beverly Hudspeth, Cory Chen, Yongle Zhao, Harry V. Vinters, Sally A. Frautschy, Greg M. Cole
Journal of Neuroscience 15 July 2009, 29 (28) 9078-9089; DOI: 10.1523/JNEUROSCI.1071-09.2009
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

  • No therapeutic effect of dietary omega-3 fatty acid and curcumin in dementia and Alzheimer�s disease
    Cesare Mancuso
    Published on: 27 July 2009
  • Published on: (27 July 2009)
    Page navigation anchor for No therapeutic effect of dietary omega-3 fatty acid and curcumin in dementia and Alzheimer�s disease
    No therapeutic effect of dietary omega-3 fatty acid and curcumin in dementia and Alzheimer�s disease
    • Cesare Mancuso, Assistant Professor of Pharmacology
    • Other Contributors:
      • Eugenio Barone

    The therapeutic effects of fish oil, rich in omega-3 fatty acids (FA), and curcumin in dementia and Alzheimer’s disease (AD) hypothesized by several preclinical studies, was recently contradicted by clinical evidence. The Rotterdam study, which involved ~6000 participants aged greater than or equal to 55 and monitored over 10 years for mortality and major morbidity, clearly demonstrated that omega-3 FA supplementation di...

    Show More

    The therapeutic effects of fish oil, rich in omega-3 fatty acids (FA), and curcumin in dementia and Alzheimer’s disease (AD) hypothesized by several preclinical studies, was recently contradicted by clinical evidence. The Rotterdam study, which involved ~6000 participants aged greater than or equal to 55 and monitored over 10 years for mortality and major morbidity, clearly demonstrated that omega-3 FA supplementation did not reduce the risk of developing dementia and AD in the elderly. Specifically, individuals with a higher fish intake had a risk of developing dementia or AD similar to that of those who usually did not eat fish (Devore et al., 2009). Parallel results were obtained by the Canadian Study of Health and Aging, in which the association between erythrocyte membrane concentration of omega-3 FA and the incidence of dementia and AD was evaluated in 650 patients aged greater than or equal to 65 (Kröger et al., 2009). In this study, no evidence of a reduced risk of dementia or AD among subjects with higher levels of plasma omega-3 FA was found over a follow-up period of about 5 years. Similar negative results were obtained in AD patients treated with curcumin. In a randomized, placebo-controlled, double-blind clinical trial, curcumin (1-4 g/day for 6 months) failed to improve cognitive performance in patients suffering from mild-to-moderate AD and had no effect on pro-inflammatory biomarkers like serum amyloid-beta-peptide and isoprostanes (Baum et al., 2008). Based on these findings, the use of omega-3 FA and/or curcumin to preserve cognitive function in the elderly seems not to have any scientific basis.

    References

    Baum L et al. (2008) Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 28:110-113.

    Devore EE, Grodstein F, van Rooij FJ, Hofman A, Rosner B, Stampfer MJ, Witteman JC, Breteler MM (2009) Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk. Am J Clin Nutr 90:170- 176.

    Kröger E, Verreault R, Carmichael PH, Lindsay J, Julien P, Dewailly E, Ayotte P, Laurin D (2009) Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging. Am J Clin Nutr 90:184-192.

    Show Less
    Competing Interests: None declared.

Related Articles

Cited By...

More in this TOC Section

Articles

  • Choice Behavior Guided by Learned, But Not Innate, Taste Aversion Recruits the Orbitofrontal Cortex
  • Maturation of Spontaneous Firing Properties after Hearing Onset in Rat Auditory Nerve Fibers: Spontaneous Rates, Refractoriness, and Interfiber Correlations
  • Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration
Show more Articles

Neurobiology of Disease

  • Choice Behavior Guided by Learned, But Not Innate, Taste Aversion Recruits the Orbitofrontal Cortex
  • Maturation of Spontaneous Firing Properties after Hearing Onset in Rat Auditory Nerve Fibers: Spontaneous Rates, Refractoriness, and Interfiber Correlations
  • Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration
Show more Neurobiology of Disease
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.